Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Merck Serono signs diabetes partnership with BMS in China

Will co-promote Glucophage (metformin) formulations

- PMLiVE

Affymax in a tailspin after Omontys recall

Makes heavy job cuts in face of bankruptcy threat

- PMLiVE

bmore creative hires Kush Rach as new business director

Independent agency appoints former Pulsar Healthcare business development director

- PMLiVE

GW Pharma says German Sativex pricing “unacceptable”

May pull MS drug from market

- PMLiVE

Bayer’s Eylea data not suitable, says IQWiG

German HTA body unhappy with Lucentis comparison data and turns down Bayer-Regeneron wet AMD drug

- PMLiVE

Former Pfizer R&D head LaMattina to advise Ziarco

He previously spent 30 years at US pharma firm

- PMLiVE

Is the new NHS guidance relevant to pharma?

The new NHS Commissioning Board has published its most important document of the year - one that will have a huge impact on the industry in 2013

Czech biotech Sotio selects Chiltern International

UK CRO will work on late-stage trials for its prostate cancer therapy

- PMLiVE

Improved health communications needed with the UK’s South Asian communities

Red Door Communications launches ethnic minority outreach programme

- PMLiVE

Novartis turns from social networking to apps for trial recruitment

Launches iPhone and Android cancer trial app in the US

- PMLiVE

Black triangle monitoring warning to be used across EU

Use of symbol is part of EMA plans to strengthen pharmacovigilance

- PMLiVE

Mixed reaction to Novo Nordisk obesity trial

Analyst says Victoza only has a modest ability to reduce weight in people with diabetes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links